Announcements

New Impact Factor for Cardiovascular Diagnosis and Therapy: 2.615

Published: 2020-06-30

We are pleased to announce that Cardiovascular Diagnosis and Therapy (CDT) has attained its latest impact factor update for the 2019 citation year: 2.615.

Cardiovascular Diagnosis and Therapy (Print ISSN: 2223-3652; Online ISSN: 2223-3660; Cardiovasc Diagn Ther; CDT) is an open access, peer-reviewed, international English-language journal indexed by PubMed/PubMed Central and Science Citation Index Expanded (SCIE). The journal publishes manuscripts that describe novel findings in the diagnosis and therapy of cardiovascular diseases including contributions related to clinical cardiology, cardiothoracic surgery, public heath, nursing, sociology, human genetics, basic sciences, education, and the environment.

Aiming for the continued development of article quality alongside the growth of the numbers of submissions, we have recently emphasized improving the publication quality and processing transparency. Some significant arrangements were made in CDT in the past few months:

1. Integration with Publons. As of April 2020, our publisher AME Publishing Company has entered into an official partnership with Publons. Thus, CDT’s peer review system is now integrated seamlessly into the Publons platform (https://publons.com/publisher/6041/ame-publishing-company). The partnership allows for the contributions of our expert peer-reviewers to be recognized anytime. For more information, see: http://cdt.amegroups.com/announcement/view/3763.

2. Reporting guidelines for original research. For a higher standard of publishing and research quality, we have introduced a series of reporting guidelines for different research types. Each original research submission to CDT is now required to follow the EQUATOR research reporting guidelines and should include a checklist. If the article is accepted, the related reporting checklist will be published online with the article. For more details, please check the updated guidelines for authors: http://cdt.amegroups.com/pages/view/guidelines-for-authors.

3. Transparent peer review process. To commit to openness and accountability, and to increase the level of transparency throughout our peer review process, our Editorial Office has decided to implement a transparent peer review process as an option for all manuscripts submitted to CDT from April 15, 2020. Click here for further information: http://cdt.amegroups.com/announcement/view/3753.

We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.

We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in cardiovascular diagnosis and therapy to bring more exciting content to readers in the coming future.


Editorial Office
Cardiovascular Diagnosis and Therapy
June 30, 2020